Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease

Journal Title: Journal of Neuroscience and Neurological Disorders - Year 2018, Vol 2, Issue 2

Abstract

Ailment repairing regiments has turn out to be arduous, despite a plenty of understanding and knowledge acquired in the past relating to the molecular underpinnings of Alzheimer’s disease (AD. Umpteen clinical experiments targeting the fabrication and accumulation have been turned fruitless to fit potency standards. The tests aiming beta-amyloid hypothesis also turned futile making it exigent for further handling tactics. The new emanation of a comparably candid, economical, and punctilious system known as gene editing have showed light in path of cure for AD by CRISPR/Cas9 gene editing. Being a straight approach this procedure has already shown assurance in other neurological disorders too such as Huntington’s disease. This review standpoint the immanent service of CRISPR/Cas9 as a remedial option for AD by aiming on specific genes inclusive of those that induce early-onset AD, as well as those that are substantial risk components for late-onset AD such as the apolipoprotein E4 (APOE4) gene.

Authors and Affiliations

Paul Jes

Keywords

Related Articles

Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease

Ailment repairing regiments has turn out to be arduous, despite a plenty of understanding and knowledge acquired in the past relating to the molecular underpinnings of Alzheimer’s disease (AD. Umpteen clinical experiment...

Endogenous archeological sciences: Physiology, Neuroscience, Biochemistry, Immunology, Pharmacology, Oncology and Genetics as instrument for a new field of investigation? Modern global aspects for a new discipline

In this work is analyzed scientific literature involved in human evolution to be used as an archeological Pathway to link different sciences in an overall new discipline. A rational classification of single evidence mak...

Cranioplasty with preoperatively customized Polymethyl-methacrylate by using 3-Dimensional Printed Polyethylene Terephthalate Glycol Mold

Cranioplasty is a reconstructive procedure for the repair of skull defects or deformities. Polymethyl-methacrylate (PMMA) is a commonly used alloplastic material when autologous bone is unavailable. However, manual shapi...

Experimental ‘hindbrain related’ syringomyelia: some mechanisms of spinal cord damage

Syringomyelia in combination with inherent or acquired hindbrain abnormalities is the non seldom and at the same time controversial issue. Purpose: The etiology and pathogenesis creates a lot of discussion. Methods: Ex...

Neuroscience, Rehabilitation and New Technologies: Perspectives and critical points for a synergistic development

The growth of Rehabilitation, in all of its field and mainly in neuro-rehabilitation applications and settings, is showing increasingly strong interaction with the growth of technology and its innovative applications.

Download PDF file
  • EP ID EP555167
  • DOI 10.29328/journal.jnnd.1001014
  • Views 45
  • Downloads 0

How To Cite

Paul Jes (2018). Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease. Journal of Neuroscience and Neurological Disorders, 2(2), 47-51. https://europub.co.uk/articles/-A-555167